Evidence map›Paper›PMID 19812540›Full record

ArticleKidney international2009

Protein microarrays identify antibodies to protein kinase Czeta that are associated with a greater risk of allograft loss in pediatric renal transplant recipients.

Scott M Sutherland, Li Li, Tara K Sigdel, Persis P Wadia, David B Miklos, Atul J Butte, Minnie M Sarwal

Open access · bronzeAbstract readValidation Study
In one paragraph

Article in Kidney international, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 59 citations in OpenAlex.

  1. The clinical impact of humoral immunity in pediatric renal transplantation.Journal of the American Society of Nephrology : JASN · 2013
    Trial
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Discovery of non-HLA antibodies associated with cardiac allograft rejection and development and validation of a non-HLA antigen multiplex panel: From bench to bedside.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2020
    Article
  8. Antibodies against ARHGDIB are associated with long-term kidney graft loss.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2019
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Transplant genetics and genomics.Nature reviews. Genetics · 2017
    Review
  15. The nephrologist of tomorrow: towards a kidney-omic future.Pediatric nephrology (Berlin, Germany) · 2017
    Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Mapping novel immunogenic epitopes in IgA nephropathy.Clinical journal of the American Society of Nephrology : CJASN · 2015
    Observational
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Scott M SutherlandDivision of Nephrology, Department of Pediatrics, Stanford University Medical Center, Stanford, CA 94305, USA. suthersm@stanford.edu
Li Li
Tara K Sigdel
Persis P Wadia
David B Miklos
Atul J Butte
Minnie M Sarwal
Stanford Medicine · USStanford University · US

Funding

MOLECULAR &CELLULAR IMMUNOBIOLOGYT32AI007290 · NIAID · STANFORD UNIVERSITY · PI Sean Curtis Bendall, Olivia M Martinez · 1985 to 2026
$27.0M
Defining Biomarkers in Pediatric Renal TransplantationR01AI061739 · NIAID · STANFORD UNIVERSITY · PI SARWAL, MINNIE M · 2004 to 2007
$1.6M
NIAID NIH HHS R01 AI061739NIAID NIH HHS R01 AI 61739-01NIAID NIH HHS T32 AI007290
6 · The paper itself

Abstract

Antibodies to human leukocyte antigens (HLAs) are a risk factor for acute renal allograft rejection and loss. The role of non-HLAs and their significance to allograft rejection have gained recent attention. Here, we applied protein microarray technology, with the capacity to simultaneously identify 5056 potential antigen targets, to assess non-HLA antibody formation in 15 pediatric renal transplant recipients during allograft rejection. Comparison of the pre- and post-transplant serum identified de novo antibodies to 229 non-HLA targets, 36 of which were present in multiple patients at allograft rejection. On the basis of its reactivity, protein kinase Czeta (PKCzeta) was selected for confirmatory testing and clinical study. Immunohistochemical analysis found PKCzeta both within the renal tissue and infiltrating lymphocytes at rejection. Patients who had an elevated anti-PKCzeta titer developed rejection, which was significantly more likely to result in graft loss. The absence of C4d deposition in patients with high anti-PKCzeta titers suggests that it is a marker of severe allograft injury rather than itself being pathogenic. Presumably, critical renal injury and inflammation associated with this rejection subtype lead to the immunological exposure of PKCzeta with resultant antibody formation. Prospective assessment of serum anti-PKCzeta levels at allograft rejection will be needed to confirm these results.

Indexed as

AdolescentChildComplement C4bEnzyme-Linked Immunosorbent AssayFemaleGraft RejectionGraft SurvivalHLA AntigensHumansImmunohistochemistryIsoantibodiesIsoantigensKidneyKidney TransplantationMalePeptide FragmentsComplement C4bcomplement C4dHLA AntigensIsoantibodiesIsoantigensPeptide FragmentsProtein Kinase CProtein Kinase C zeta

Identifiers

PMID19812540
PMCPMC4464694
OpenAlexW2001121246

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.